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Abstract 
Neither high theoretical efficacy of disease control tools, nor diagnostic accuracy, nor good compliance, 
nor adequate coverage can lead on its own to the final goal of community effectiveness. There is a complex 
relationship between these factors. The different steps in the process leading to effective health care in the 
community are discussed on the basis of biomedical and health systems research activities of the Swiss 
Tropikal Institute. Schistosomiasis and malaria control provide the background to problems related to the 
efficacy of tools. In particular, information on the trial of a malaria vaccine candidate (SPf66) is given. Ap- 
proaches to the rapid, accurate and economical diagnosis of communities at risk are discussed with reference 
to Schistosoma haematobium and S. mansoni. Health service support projects in Tanzania and Chad are 
presented to exemplify problems linked to the compliance of users/providers and coverage. Finally, it is 
shown that community effectiveness depends on the highest possible success rate for each step. This re- 
quires the co-operative efforts of all those involved: the scientist, the manager, the community health 
worker and, lastbut not least, the community itself. 
Introduction 
The year 2000 has been set as a benchmark for the 
completion-or near-completion-of the ‘Health for All’ 
agenda. Moving towards this goal involves regular assess- 
ment of the health development process, and of what has 
been achieved in research and direct health service sup- 
port activities. Many important advances have indeed 
taken place in the diagnosis, prophylaxis and therapy of 
communicable diseases. New, safe and efficacious drugs 
such as praziquantel, ivermectin, benzimidazoles and 
mefloquine have offered new approaches in drug therapy 
at both the individual and community levels. Novel sero- 
logical tests, the polymerase chain reaction technology 
with specific gene probes, and the establishment of 
simple field tests, have substantially facilitated clinical 
and community diagnosis. Vaccine development has 
helped to improve existing vaccines as well as to intro- 
duce new ones. For some diseases new tools have become 
available for national and regional control programmes; 
for example, insecticide impregnated bed nets to reduce 
malaria-related morbidity and mortality, and vector con- 
trol strategies based on the long-term experience of the 
Onchocerciasis Control Project in West Africa. 
Impressive advances have been made in the implemen- 
tation of the primary health care (PHC) strategies and in 
the management of health services. However, although 
many countries have adopted the PHC concepts and es- 
tablished an implementation strategy, there still appear 
to be major problems in setting up a decentralized, 
health district management approach that considers the 
full spectrum of potential users and all providers (gov- 
ernmental, non-governmental, traditional, private) 
(WHO, 1988). 
The ultimate aim of developing efficacious disease con- 
trol tools and of tailoring health service management to a 
given socio-ecological setting is to reach community ef- 
fectiveness. The thing that counts in terms of bringing 
real improvement in health is not the theoretical efficacy 
of the tool, but its effective application. It is the aim of 
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COMMUNITY 
EFFECTIVENESS 
Figure. The path from the efficacy of a control tool to its community ef- 
fectiveness. An efticacious tool must reach the target group (diagnostic ac- 
curacy needs to be high), users and providers should comply, and the 
whole action requires a high level of coverage in order to retain the eff- 
cacy of the tool at the level of a community (after VLASSOFF & TANNER, 
1992). 
this review to invite readers to take a walk from efficacy 
to community effectiveness, following the staircase illus- 
trated in the Figure. We illustrate the steps of this path 
by examples from recent and continuing studies that are 
part of the health research and service support pro- 
grammes undertaken by the Swiss Tropical Institute in 
Base1 (STI), within a framework of national and interna- 
tional collaboration in both rural and urban settings in 
Tanzania and Chad. 
Developing efficacious tools 
The first step represents the availability of efficacious 
control tools. The development of such tools will be de- 
scribed with reference to work on schistosomiasis and 
malaria done by teams at the Ifakara Centre in Tanzania 
(formerly the Swiss Tropical Institute Field Laboratory). 
In schistosomiasis, a safe drug, praziquantel, is avail- 
able. It has been used widely and successfully in many 
endemic settings over the past 10 years. The question of 
its efficacy may therefore not appear to be crucial. How- 
ever, recent reports on unexpected possible failures of 
praziquantel and high side-effect rates in a large-scale 
project in northern Senegal (WHO, 1992) point to the 
need to assess efficacy in a broad range of different en- 
demic and socio-ecological situations. In order to provide 
more information for inter-site comparisons, studies in 
Tanzania attempted to investigate the efficacy of 2 doses 
of praziquantel (20 vs. 40 mg/kg, single oral dose), not 
only in clearing Schistosoma haematobium parasite loads 
but also in reducing morbidity among children (HATZ et 
al., 1990). These studies showed that, at the given level 
of S. haematobium endemicity, the lower dose of 20 
mgikg was equally efficacious in gradually reducing blad- 
der and kidney morbidity, as assessed by sonography, 
within 6 to 12 months after treatment. This finding 
clearly leads to substantially lower treatment costs for 
this endemic setting, as the drug costs are crucial in any 
morbidity control strategy (GUYATT et al., in press). 
Another line of research in the development of tools 
for schistosomiasis control was the assessment of the fea- 
sibility of using plant molluscicides in snail control. Syn- 
thetic molluscicides that need to be imported are too 
costly for Tanzania, given the low level of resources allo- 
cated to health per caput (about US$ 1.20; 1991/92 bud- 
get and exchange rate). The first step included identify- 
ing local plants known to have molluscicidal properties 
and looking at their distribution. This knowledge came 
firstly from members of the local population, who indi- 
cated the plants commonly used for fishing, and sec- 
ondly-to a much smaller extent-from the scientific lit- 
erature (HAERDI, 1964). Swartzia maduguscariensis 
(Desvaux) (Leeuminosae) was identified as the most suit- 
able candidate, and a series of laboratorv and field tests 
was carried out, including toxicity and mutagenicity as- 
savs (SUTER et al.. 1986: BOREL & HOSTETTMANN. 
1987): The most interesting results were not only the 
identification of the saponin responsible for the mbllus- 
cicidal activity (oleanolic acid: 3-o+D-glucuronopyrano- 
syl (1-3)-cw-L-rhamnopyranoside) and the measurement 
of its toxicitv (100% lethal concentration=3 ma/L for 
Bulinus spp.-and Biomphaluriu spp ) but also &e fact 
that field trials established the con&ions and determi- 
nants for efficacious use in the various communities 
(TANNER, 1989a). 
With malaria, the problem of finding efficacious 
methods for control has by no means been solved. In 
Tanzania, there are few areas in which there is little or no 
malaria, and most of the country experiences intense 
transmission resulting in substantial morbidity and mor- 
tality (KILAMA & KIHAMIA, 1991). In general, the situ- 
ation has deteriorated since CLYDE (1967) mapped the 
distribution of endemicitv. Most of the Dooulated areas 
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at low altitude are holoendemic, with transmission for 
more than 6 months of the year. This is also the situation 
in the Kilombero vallev, where the Ifakara Centre has 
been doing research onmalaria for many years. An ana- 
lysis of the endemic situation was undertaken, and 
potential tools such as insecticide impregnated bed nets 
and a vaccine candidate are now being evaluated at com- 
munity level. 
The major vectors belong to the Anopheles gambiae 
complex and the A. funestus group. Plasmodium falcipa- 
rum is the predominant parasite species, and is acquired 
by about 80% of infants bv the age of 6-8 months. Para- 
site prevalences then remain above 80% throughout 
childhood, but are somewhat lower in adults (SMITH et 
al., in press). This study also showed that, although mos- 
quito densities are seasonal, transmission occurs all the 
year round, and neither the parasite prevalence nor the 
infant conversion rate show any marked seasonality. Fi- 
nally, morbidity surveillance in the communitv indicates 
that the prevalence of measured fever (axillary tempera- 
ture 237.X) is greatest towards the end of the first vear 
of life. Among children aged l-5 years the prevalence of 
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fever is around 5%, with about 30% of this morbidity 
being attributable to raised P. fulcibarum oarasitaemia 
(S~~?~etal., in press). a s a 
The Ifakara Centre started research on malaria trans- 
mission and control in the 1960s (FREYVOGEL 8z KI- 
HAULE, 1968). This initial research was later followed by 
longitudinal studies on the development of resistance to 
antimalarial drugs (KOELLA et al., 1990) and on the de- 
velopment of the immune response to different euitones 
of the P. falciparum circumsborozoite protein (TENDER 
et al.. 1986b; DEL GIUDICE et al.. 1987. 1990). Later the 
Ifakara Centre became the base for the ‘Kilombero Mala- 
ria Project (KMP); a collaboration between the Ifakara 
Centre, the STI, the Universities of Waeenineen and 
Nijmegen in the Netherlands, and the Immunolcbgy Re- 
search and Training Laboratories of the World Health 
Organization (WHa), Geneva. This project aims to 
define and validate operationally useful indicators of 
transmission and morbidity, in order to monitor and 
evaluate intervention studies and the impact of disease 
control at the community or health facility level. 
After a series of baseline studies in 1989 and 1990, a 
randomized trial was started in 2 villages to evaluate the 
use for personal protection against malaria of bed nets 
and various locally-available fabrics (e.g., curtains made 
of fertilizer bag material) impregnated with insecticides. 
The primary outcome of interest is morbidity, detected 
through household surveys undertaken every 2 weeks. 
This study, together with the many other bed net trials at 
different sites supported by WHO/Tropical Disease Re- 
search (TDR), the UK Overseas Development Adminis- 
tration (ODA) and the International Research and Devel- 
opment Corporation of Canada, is seen as a contribution 
to the question of whether insecticide-treated bed nets 
will be effective in areas of Africa where the pressure of 
malaria infection is continuous and very high. 
Parallel to this set of intervention studies, in 1992 the 
Ifakara Centre also became the site for the double-blind, 
randomized placebo-controlled phase III trial of SPf66, a 
candidate malaria vaccine (PATARROYO et al., 1988). 
SPf66, a synthetic polymer that contains sequences from 
several parasite antigens, has undergone extensive pre- 
clinical and clinical tests in South America, which have 
shown it to be safe and immunogenic in humans (AMA- 
DOR et al., 1992; PATARROYO et al., 1992). Based on a 
WHO/Pan-American Health Organization commission 
report in 1990, and in view of the need to establish the 
efficacy of SPf66 in areas of very high and continuous 
transmission, a double-blind randomized placebo-con- 
trolled trial was planned. It aims to determine whether 
SPf66 is effective in reducing the prevalence and intens- 
itv of oarasitaemia and the incidence of clinical attacks of 
malaria in young Tanzanian children. This phase III trial 
represents a collaboration between the National Institute 
for Medical Research of Tanzania? the STI, the Consejo 
Superior de Investigaciones Ciennficas (CSIC) of Spain, 
and the London School of Hygiene and Tropical- Me: 
dicine, and receives financial sunnort from CSIC. 
WHOiTDR and STI. 
. - 
The trial was launched in August 1992 after all the 
necessary technical and ethical clearances had been ob- 
tained. A preliminary randomized double-blind placebo- 
controlled- study of -the safety and immunogenicity of 
SPf66 was conducted in 12 adult Caucasians and 30 adult 
male volunteers from the endemic area, followed by a 
similar study among 50 children arred l-5 vears. These 
studies allow close monitoring of any side-effects of the 
vaccine in a group similar to the target group of the main 
trial. 
Providing the results of these preliminary studies are 
considered satisfactory by the monitors, a double-blind 
randomized placebo-controlled trial of vaccine safetv and 
efficacy will be undertaken in 600 children aged l-5 
years in Idete village, 20 km west of Ifakara. This main 
part of the trial could start in March 1993. Children will 
be individually allocated at random to receive 3 doses of 
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Table. Health development projects for which the Swiss Tropical 
Institute acts as executing agency on behalf of the Swiss Development 
Co-operation 
Project/Programme country Content 
Moyen Chari Chad 
Chari Baguirmi Chad 
Central Hospital, Medical 
Department, N’djamena 
Chad 
National Public Health 
School, N’djamena 
Co-ordination, N’djamena 
Chad 
Chad 
Urban health, N’djamena 
Urban health, Dar es 
Salaam 
Kilombero Health Research 
and Support Programme, 
Ifakara 
Chad 
Tanzania 
Tanzania 
Rural district support 
Rural/semi-urban district 
support 
Hospital management as a 
part of a district referral 
system support 
Training and manpower 
management 
Ministry of Health support 
and programme co- 
ordination 
Urban district support 
Urban district support 
Research and rural district 
support 
SPf66 or of placebo over a period of 6 months. The fol- 
low-up will last for 12 months after the third dose, and 
will consist of active and passive (at the village dispen- 
sary) case detection. Outcome measures include infec- 
tion, level of parasitaemia, and number of malaria epi- 
sodes. As additional measures, the packed cell volume 
and the exposure to mosquito bites will be monitored 
and chloroquine consumption determined. Sera will be 
collected at regular intervals. A detailed description of 
the trial will be given by P. Alonso, M. Tanner and T. 
Teuscher*. 
If the trial goes well, the codes will be broken bv Au- 
gust 1994, allowing the assessment of vaccine efficacy as 
well as further studies on the immunoloeical oroliles in 
this study population. The study will -have’sufficient 
power to detect a 50% reduction in the incidence and 
nrevalence of overall and high intensitv narasitaemia, and 
io detect a 50% reduction in the incidence of clinical ma- 
laria. Hooefullv. this trial will not onlv orovide us with a 
scientifically sound assessment of the’ efficacy of the 
SPf66 vaccine, but also equip us with a valuable new tool 
for malaria control. 
Diagnosing communities at risk 
Once an efficacious control tool has become available, 
the next step involves developing a strategy to deliver it 
to the people who need it, either whole communities or 
groups within the community. In countries where tropi- 
cal diseases are endemic the delivery of control tools 
within a PHC approach faces the constraint of limited 
financial. material and human resources. and also the dif- 
ficulty of the satisfactory deployment of those resources 
that are available. This can be illustrated in the case of 
malaria or schistosomiasis by the inability to deliver effi- 
cacious drugs to defined target groups, even though the 
drug and enough trained staff are available (BRADLEY, 
1991). These problems could be partly overcome with 
more use of the potential of community participation, 
which includes the kev issue of addressing the com- 
munity or the groups within it that are in need. 
The potential for community participation is not un- 
limited, since people are confronted with a multiplicity of 
problems in their daily lives. Health is only one among a 
vast range of issues and is in itself a broad and diverse 
area with potentially conflicting priorities. If com- 
munities are to participate in a programme, prioritizing 
health or community development problems cannot only 
be based on normative needs, but should include the per- 
ceived needs, if a disease control programme is to be suc- 
‘Paper entitled ‘A trial of SPf66, a candidate malaria vaccine,’ in 
preparation for Vaccine. 
cessful and truly based on PHC principles (TANNER et 
al., 1986a; TANNER, 1989a; VLASSOFF, 1992). 
Communities which bear a large burden of morbidity 
or mortality, or both, are likely to be more concerned 
and therefore likely to participate. Furthermore, identifi- 
cation of these target groups can substantially improve 
the cost-effectiveness of an intervention (JAMISON & 
MOSLEY, 1992). Target groups may be defined geo- 
graphically, in the case of focal diseases, as ‘high-risk 
communities’, or they may be defined as a particular seg- 
ment of the community, according to age, occupation or 
other relevant criteria. 
Whatever the target group(s), the key issues in imple- 
menting a targeted control strategy of proven efficacy are 
coverage and diagnostic accuracy, at both the group and 
the individual level. The intervention has to reach the 
target group(s) and be delivered to them as widely as 
possible. Thus, one tries to avoid the group(s) not in 
need of the particular intervention, with the aim of 
achieving high coverage efficiency (TANNER, 1989b). 
The concept of coverage efficiency, as proposed by ROSSI 
& FREEMAN (1985), is expressed as follows: 
No. in need served No. not in need served 
- x 100 
Total no. in need Total no. served 
An increasing positive number (towards 100) indicates 
appropriate targeting, while negative numbers indicate 
that inappropriate targets are being served. 
The concepts of diagnostic accuracy and coverage can 
be illustrated by work on urinary schistosomiasis done by 
the Ifakara Centre over the past 8 years. Particular refer- 
ence will be made to the experience in the Kilombero 
and Kilosa Districts of the Morogoro region in central 
Tanzania (TANNER, 1989a; LENGELER et al., 1991a, 
1991b). 
The distribution of infection and morbidity of schisto- 
somiasis is highly focal (JORDAN & WEBBE, 1982). The 
disease is chronic and its impact on people’s well-being, 
working efficiency and productivity is measurable only 
above a (community-specific) prevalence and intensity 
threshold. Consequently, schistosomiasis control aiming 
primarily at morbidity control and facing resource con- 
straints inevitably requires identification of high-risk 
communities and-within these communities-the ident- 
ification of high-risk individuals, i.e. those with mor- 
bidity or at risk of developing it. 
The Ifakara Centre was approached in 1988 by the Re- 
gional Medical Officer, who requested an investigation of 
the schistosomiasis situation in the Kilosa district (14 000 
km*, 370 000 inhabitants), adjacent to the Kilombero 
district where the Ifakara Centre is located. The aim was 
to identify the areas of high risk which would be targets 
for control measures. Earlier studies in the area had re- 
vealed the potential of school-based questionnaires 
(LENGELER et al., 1991a), so we chose to work entirely 
through the 168 primary schools, as they provided good 
coverage of the area. Simple questionnaires were sent by 
the district education office to all primary schools in the 
district. A first form, investigating the ranking of the 
most common diseases and symptoms in this area, was 
completed by all headteachers. A second form was ad- 
ministered by the teachers to 100 of the children in each 
school. It contained 3 questions about the ranking of re- 
cent experience of diseases, symptoms and signs. The 
complete description of the approach and the structure of 
the questionnaires are given by LENCELER et al. (1991a, 
1991b, 1992). 
The interviews were carried out without any major 
operational problem, and 164 of 168 schools returned the 
completed forms within 4 weeks (97.6%). Over 15 000 
children were interviewed by their teachers. The results 
of the questionnaires were subsequently validated by rea- 
gent stick testing for haematuria in 73 schools, in order 
to define the diagnostic accuracy of the questionnaire 
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method in them, i.e. to assess the performance of the 
questionnaires in detecting the communities with high S. 
haematobium-related morbiditv. The correlation between 
the questionnaire results and the biomedical testing were 
excellent (C-0.55 for the teacher’s responses, P<O.OOOl; 
r>0.84 for the children’s answers, P<O.OOOl). The cal- 
culated performance of the test was impressive. Sensitiv- 
ity was 90% and specificity 91%; the positive predictive 
value reached 88%, and the negative predictive value was 
as high as 93%. The approach in the Kilosa district in- 
cluded the testing of haematuria by the teachers them- 
selves, following a one-day training seminar. A validation 
of this school-based testing in 18 schools confirmed that 
teachers can perform this &agnostic step in a most satis- 
factory manner. 
Since the whole of the two-step approachyuestion- 
naires followed by reagent-strip haematuria testing-was 
carried out through the school administrative system, the 
cost was only US$19 per school (treatment excluded). 
This is at least 8 times cheaper than a vertical control ap- 
proach involving a specialized team touring the same dis- 
trict and performing urine analyses. For reagent stick 
testing alone, done by the teachers, the cost was US$O.42 
per child (treatment excluded). 
In addition to the information the questionnaires pro- 
vided about schistosomiasis, important knowledge about 
community priorities and demands for control could be 
gained from the teachers’ answers. The results showed 
that, at low and medium prevalences of morbidity 
(<40%), schistosomiasis was not a disease that was con- 
sidered a problem at community level. However,, once 
the level of haematuria reached 40% among children, 
there was a demand for control action, and schistoso- 
miasis was consistently cited among the top 3 diseases, 
often ahead of malaria. This information was not onlv 
valuable for planning community-based control, but will 
also allow control strategies to be better targeted in the 
future. 
The experience from the Kilombero and Kilosa dis- 
tricts confirmed the value of disease perception for the 
cost-efficient community diagnosis of schistosomiasis and 
the planning of control activities. It prompted the Social 
and Economic Research component of TDRiWHO to 
launch a multi-country study based on the design of the 
Kilosa study, with the aim of replicating and validating 
the approach in different socio-ecological settings in Af- 
rica where schistosomiasis is endemic. This study was 
conducted by teams of biomedical and social scientists (at 
least one of each discipline per country), named the ‘Red 
Urine Study Group’. They worked in Cameroon, Congo, 
Ethiopia, Malawi, Zaire, Zambia and Zimbabwe from 
April 1990 to April 1992. As a major addition, in one 
country (Zaire) the value of the uestionnaire approach 
was also assessed for S. mansonz m ections. 
..I 
Totals of 67 000 children and 1004 teachers were inter- 
viewed by questionnaires (overall return rate: 89%), and 
36 000 children in 358 schools were tested by a biomedi- 
cal test (‘Red Urine Study Group’, paper in preparation). 
Preliminary results showed that the approach worked 
well in 5 of 7 countries bv reaching a diagnostic nerfor- 
mance comparable to that in the Tanzanian study. In all 
countries. return rates were over 80%. and the auestion- 
naire approach showed a median sensitivity of’ 88% a 
median snecificitv of 71%. a median oositive medic&e 
value of ?4%, and a median negative predictive value of 
85%. The multi-country study also indicated the poten- 
tial of this questionnaire approach for intestinal schisto- 
somiasis. Reasons for success or failure were investigated 
by a thorough qualitative follow-up in each area (‘Red 
Urine Study Group’, paper in preparation). 
After the extensive validation, this rapid assessment 
approach will clearly find its position within future 
strategies for morbidity control in schistosomiasis, since 
it provides an entry point by mapping high risk sites or 
communities, making it possible to target the interven- 
tions. It becomes particularly interesting in any situation 
when resources for control are limited and/or compete 
with other disease control priorities. A recent analysis of 
cost-effective strategies in the morbidity control of schis- 
tosomiasis revealed the potential of the questionnaire ap- 
proach as a first step in stratifying an area (district, re- 
gion) into low-risk and high-risk communities, so that 
each area can subsequently be covered by the most cost- 
effective treatment strategy, i.e. treatment through exist- 
ing services or special programmes (GUYATT et al., in 
press). 
As the questionnaire approach is designed to be inte- 
grated into a country’s normal administrative structures 
in health and education, it is not bound to any vertical or 
special programme, but can run within the existing 
health and education services at low cost. It also has 
potential as a diagnostic tool for many other chronic dis- 
eases, such as onchocerciasis and Bancroftian filariasis, in 
which either the disease entity or its symptoms and signs 
are perceived by the community (LENGELER ef al., 
1992). Currently, a number of studies are exploring the 
z;he;iptential of this questionnaire approach in Africa 
Once efficacious tools have been developed, and the 
target groups have been identified, the problem that re- 
mains is how the different components of the control 
strategy can actually be delivered. Delivery is partly a 
question of the availability of resources, but it is also a 
question of managing those resources. 
Managing the health system at District level 
In the earlier years of the Ifakara Centre, the main em- 
phasis was on fundamental research. But the Centre was 
always very closely linked to the district, and in 1987 the 
ST1 decided to become involved in direct project im- 
plementation. One main argument in favour of this far- 
reaching decision was that it would provide the oppor- 
tunity, not only to generate research results within a 
health programme, but to translate them more directly 
into action. 
The decision did, of course! also bring additional re- 
sponsibilities. Today, the ST1 is the executing agency for 
8 major health projects, not only in Tanzania but also in 
Chad. These projects are either based on bilateral agree- 
ments or on contracts with the partner countries. 
The focus of these projects is on the district, the natu- 
ral meeting point of ‘bottom-up’ planning and organiza- 
tion and ‘top-down’ planning and support; the place 
where community needs and national priorities can be 
reconciled (TARIMO, 1991). 
The emphasis of all ST1 nroiects involving health ser- 
vice support activities is on-the implementazon of oper- 
ational nlans. which are established with the oartners. 
The disirict health plans cover both infrastrucfural and 
functional rehabilitation, and the strengthening of dis- 
trict and regional health authorities. Each project in- 
cludes 2 important components: audit and research- 
though the borderline between the two is not always 
clear. Audit has recentlv been defined as the need to 
prove ‘that things are done right’ (EDITORIAL, 1992). 
This is an important element, not only for the constant 
evaluation of the project itself, but because of the 
necessity of justifying our expenses to our donor agen- 
cies. However, all the projects also have a strong commit- 
ment towards research, which includes the development 
of new and innovative approaches to the multiple prob- 
lems of district health systems. 
As a preparation for the Dar es Salaam Urban Health 
Project, a major household study was undertaken in 1990 
to identify user and provider patterns (MBURU, 1990). It 
identified and partly quantified some of the shortcomings 
of the Dar es Salaam health svstem. 
An important finding was-the serious overcrowding of 
central health facilities. The oeoole interviewed ex- 
pressed their wish to use health f&ilities which were easy 
to reach, and a common complaint was about the high 
transportation cost to centrally located health facilities. 
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However, despite the cost of reaching these central fa- 
cilities, they remained attractive to patients when drugs 
could not always be found in peripheral facilities. 
The lack of drugs in peripheral units was not a surpris- 
ing finding, but its extent was unexpected. In most of 
these health facilities even the simplest and most basic 
items, such as chloroquine and basic medical equipment, 
were not available. 
On the basis of these results, the reject was concen- 
trated on peripheral units in terms o P . physical rehabilita- 
tion and the provision of drugs. One of the working hy- 
potheses was that the existence of rehabilitated 
peripheral health units, where drugs were available, 
would reduce the pressure on the centrally located health 
centres, some of which saw up to 2000 patients a day. 
A major activity at the initial stage of the project was 
the establishment of an inventory of health providers in 
Dar es Salaam and the scope of their activities. It gave a 
clear view of health care provision in the city, and pro- 
vided detailed information on almost 200 health care fa- 
cilities, governmental and non-governmental. The latter 
group includes facilities provided by missions and other 
voluntary agencies and by industrial corporations and 
profit-oriented private services. 
Though there are considerable differences between the 
2 groups of providers, the study revealed that govern- 
mental facilities are actually better than their reputation. 
Governmental facilities provide most of the emergency 
care. Furthermore, they have almost a monopoly on 
preventive activities. These are, of course, linked to ver- 
tical, mainly externally-supported programmes, such as 
the Extended Programme of Immunization. The fact that 
the non-governmental sector carries out so little preven- 
tive activity demonstrates that prevention is economically 
not interesting. 
An exercise complementary to the inventory of health 
facilities was the determination of the cat&n-rent area for 
each of them. This approach has been a valuable instru- 
ment to clarify user patterns and identify the areas of 
underutilization. 
Continuing this line of identifvine determinants ofhealth 
care provisi&, a fruitful collaboration with the Urban 
Health Programme of the London School of Hygiene and 
Tropical Medicine has been established. A comparative 
study (KANJI et al., 1992) was undertaken to determine the 
quality of care, as defmed by professionals and users, in 
governmental nd voluntary/missionary health facilities. A 
locallydefmed quality score was worked out, in which 
100% was the optimum value. 
One of the striking results for overall quality was not 
that it was low, but that it was rated similarly (60%) in 
the governmental and in the voluntary/missionary health 
facilities. On the other hand, the rating for interpersonal 
qualities, e.g. the quality of attention as perceived by the 
users, was generally better in the non-governmental sec- 
tor. The 1992 study, like that by MBURU in 1990, 
showed that the major criterion for the users was the 
availability or non-availability of drugs. 
One complementary measure carried out by the pro- 
ject was the provision of essential drugs. The arrival of 
drugs in governmental facilities provided a quasi-natu- 
ral experiment, in which the impact of this measure 
could be assessed. A randomized study was able to 
show that the overall utilization of -governmental 
health facilities increased bv aooroximatelv 10%. and 
that a large majority of the-patients actually received 
the prescribed drugs. An interesting result is that the 
utilization of centrally located governmental facilities 
has gone down significantly. This result validates the 
hypothesis that the concentration of effort on the im- 
provement of peripheral units would reduce the wor- 
kload at the central units. 
In order to monitor the impact of the nroiect, a demo- 
graphic surveillance system has been established jointly 
with a study grotto from the Muhimbili Medical Centre. 
which is supported by the ODA and by scientific exper: 
tise from Newcastle University, UK. Three distinct areas 
of Dar es Salaam have been selected, with approximately 
15 000 households comprising 60 000 individuals. 
The potential applications of this demographic sur- 
veillance system are very wide-ranging. Besides sentinel 
monitoring of activities, it will provide a basis for health 
systems research, as it provides a reliable denominator. 
Particular fields of interest for the next stages are beha- 
vioural and ethnographic aspects of health, including 
gender issues and the potential for stimulating com- 
munity participation, with a view to creating a platform 
where the community and the providers of health care 
can meet and discuss their respective needs and de- 
mands. Another series of studies will look at the effects 
of the improved governmental health facilities on health- 
seeking behaviour. 
Finally, health expenditure issues will also be an im- 
portant topic, because user charges are about to be intro- 
duced in Tanzania. The modalities of this introduction 
have not yet been decided upon by the Tanzanian gov- 
ernment, though a proposal has been elaborated (ABEL- 
SMITH & RAWAL, 1992). This pronosal is based on levy- 
ing a fee per drug item. The- project is exploring 
ooerationallv easier alternatives. such as ‘flat’ fees. The 
ahernatives for cost-recovery in’governmental health fa- 
cilities will be tested and compared. The users’ views at 
household level, and the requirements of the providers, 
will be taken into account. 
In Chad, some of the problems in urban health are 
similar. In N’djamena, the project teams have just 
started a large scale, randomly sampled household study, 
which will determine the health-seeking behaviour of ap- 
proximately 600 households with an estimated popula- 
tion of 3000. This quantitative approach will be com- 
plemented by focus group discussions to obtain an 
understanding in depth of the perception of providers 
and users of specific aspects of health care services, in- 
cluding the nutritional rehabilitation centres. 
The results of these continuing studies, as part of the 
health programmes in both countries, should make it 
possible for health service managers to tailor services for 
a given socio-ecological setting, and to make the pro- 
grammes responsive to the needs and demands of the 
potential users. In addition, these studies also provide 
key information which could be used to increase the 
compliance of users and providers, and for achieving 
high coverage levels. 
Conclusions 
Having walked the path to community effectiveness 
not only makes us realize what a long and laborious jour- 
ney it is, but also the potential of exploring each step. 
Maximal community effectiveness represents the prob- 
ability that each step has the highest possible success 
rate. Thus, we must aim at investing our resources in 
each step, which means that we require the laboratory 
studies to generate the high success rates for efficacious 
tools, and we need the field work to strengthen the appli- 
cation of the efficacious tools. In this context, field work 
does not mean only epidemiological, operational or 
health systems research studies. It includes the linking of 
these research activities with the health and development 
sector and its routine tasks, the management of health 
services and health promotion. 
This finally shows us very clearly that the walk to- 
wards community effectiveness i not a lonely journey for 
the scientists or the community health workers; right 
from the beginning, it is a joint venture. In our various 
health service support and research projects we aim to 
put this concept into practice, and to follow the words of 
DONABEDIAN (1986) ‘... the world of ideas and the world 
of action are not separate..  ,but inseparable parts of each 
other. Ideas in particular, are truly pointed forces that 
shape the tangible world. The man and woman of action 
have no less responsibility to know and understand than 
does the scholar.. ‘. 
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